News / Press Release
| Displaying 11 to 20 of 87 | Previous 10 1 2 3 4 5 6 Next 10 |
October 14, 2008
BioDiscovery Releases Nexus Expression – A Fresh Approach to Gene Regulation Analysis
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression for gene expression analysis.
September 12, 2008
M. D. Anderson Cancer Center Expands its Site-License for BioDiscovery’s Nexus Copy Number Software
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that M. D. Anderson Cancer Center in Houston, TX has expanded its site-license for Nexus Copy Number, an intuitive tool designed specifically for scientists to efficiently analyze and visualize chromosomal aberrations from microarray data.
June 3, 2008
Roche NimbleGen and BioDiscovery Form Strategic Alliance to Enhance CGH Microarrays, Software and Service
Roche NimbleGen Inc., a company of Roche Applied Science, announced today that it has formed a strategic alliance with BioDiscovery, Inc. to offer complete solutions to comparative genomic hybridization (CGH) microarray customers. The new high-density 2.1 million probe (HD2) arrays of Roche NimbleGen combined with industry-leading proprietary software, Nexus Copy Number, of BioDiscovery bring unprecedented power and ease in whole-genome CGH analysis.
March 25, 2008
BioDiscovery Releases Nexus Copy Number Professional Version 3 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Copy Number Professional Version 3, an efficient, scalable, and intuitive means for research scientists to transform their raw genomic data into biological insights.
March 6, 2008
NCI has Acquired a Site-License for BioDiscovery’s Nexus Copy Number Software
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today that the National Cancer Institute has obtained a site-license for Nexus Copy Number, a powerful tool for analysis and visualization of chromosomal aberrations from microarray data.
February 1, 2008
BioDiscovery Releases ImaGene 8.0 for Expression and aCGH Microarray Analysis
BioDiscovery Inc., the leading developer of integrated software solutions for microarray based research announced today the release of ImaGene 8.0 for microarray image analysis. The new features include improved auto-gridding, faster processing for highly dense arrays, and support for multi-sample arrays.
November 13, 2007
BioDiscovery Joins Illumina Connect Bioinformatics Program
BioDiscovery announced today that it joined Illumina Connect, a bioinformatics program offered by Illumina, Inc., for downstream analysis of microarray data.
October 16, 2007
Biodiscovery Releases Nexus CGH Version 2 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of NEXUS CGH version 2, the first commercial software tool that provides easy, fast and powerful platform independent and cross-platform analysis of multiple array-based DNA copy number data sets, simultaneously.
July 12, 2007
BioDiscovery Releases NEXUS CGH for Analysis and Visualization of DNA Copy Number Data
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research announced today the release of NEXUS CGH, a unique and novel tool for analysis of array CGH-based data from multi-array experiments supporting any platform, including Agilent, Nimblegen, Affymetrix, Illumina, Empire Genomics, and most home-spotted arrays.
April 10, 2007
BioDiscovery Releases GeneDirector 3.5 Microarray Data Management Platform
ioDiscovery Inc., the leading developer of integrated software solutions for microarray based research announced today the release of GeneDirector 3.5 featuring extended data management support for Affymetrix, Illiumina and Agilent microarray platforms.